4//SEC Filing
Sawaf Aziz 4
Accession 0001415889-25-005353
CIK 0001583107other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 7:30 PM ET
Size
4.9 KB
Accession
0001415889-25-005353
Insider Transaction Report
Form 4
Sawaf Aziz
SVP & CHIEF FINANCIAL OFFICER
Transactions
- Tax Payment
Ordinary Shares
2025-02-20$9.66/sh−13,751$132,835→ 299,138 total
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001961289
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 7:30 PM ET
- Size
- 4.9 KB